Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.

Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.

Item
http://www.wikidata.org/entity/Q51309418
Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation.The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients.Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study.Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study.Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know.A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicityMedium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted From Twice-Daily to Once-Daily TacrolimusConversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy.Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus.Quantification of Interstitial Fibrosis in Renal Allografts and Clinical Correlates of Long-Term Graft Function.Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.
P2860

Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.

Item
http://www.wikidata.org/entity/Q51309418
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Comparison of pharmacokinetics ...... e after renal transplantation.
@en
Comparison of pharmacokinetics ...... e after renal transplantation.
@nl
type
label
Comparison of pharmacokinetics ...... e after renal transplantation.
@en
Comparison of pharmacokinetics ...... e after renal transplantation.
@nl
prefLabel
Comparison of pharmacokinetics ...... e after renal transplantation.
@en
Comparison of pharmacokinetics ...... e after renal transplantation.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Comparison of pharmacokinetics ...... e after renal transplantation.
@en
P2093
P304
P31
P356
10.1097/TP.0B013E31826BC400
P433
P478
P577
P698